Galectin Therapeutics GALT
NASDAQ GALT
$3.29 -0.09 (-2.66%)
At close: Nov 11, 2026 · 4:00 PM EST

Galectin Therapeutics (GALT) Interest Paid (2009 - 2014)

Updated

Analysis

Galectin Therapeutics (GALT) Interest Paid (2009 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -1.78 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 283.00 Mn
10 Galectin Therapeutics 224.13 Mn 167.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 114,000.00
Mar 31, 2013 114,000.00
Mar 31, 2012 114,000.00
Mar 31, 2011 114,000.00
Mar 31, 2010 114,000.00
Mar 31, 2009 114,000.00
API Access

Galectin Therapeutics Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=GALT&period=max&api_key=YOUR_API_KEY